The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein
David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity. TheSpineCommunity is an online support community for individuals affected with conditions of the spine, join the conversation here.
Question: What are the best exercises [...]
Doctors have reported the results of a novel targeted therapy that may represent a new treatment option for individuals with Crohn’s disease. Risankizumab is a humanized monoclonal antibody targeting the p19 subunit of interleukin-23, and is being developed for Crohn's disease. Other IL-23 inhibitors are currently under study for inflammatory [...]
Crohn’s disease is an idiopathic, chronic, inflammatory process that can affect any part of the gastrointestinal (GI) tract from the mouth to the anus. Individuals with Crohn’s disease often experience periods of symptom relapse and remission. Appropriate medical and surgical therapy help patients to have a reasonable quality of life, [...]
Almost 700,000 people in the U.S. suffer from Crohn’s disease however each individuals experience with the chronic illness is unique and can differ significantly from others. For some individuals, flare-ups only occur every few years, others may never get relief and ultimately require surgical intervention.1 New research may explain why the disease [...]
Managing a chronic disease, such as Crohn’s disease or ulcerative colitis is difficult enough to begin with and can be made much more difficult if you are unable to afford your medications or health insurance premiums.
To help ease the burden of medication costs, many drug or pharmaceutical companies [...]
